Phase I trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder

被引：0
|
作者：
Dalbagni, G
Russo, P
Sheinfeld, J
Mazumdar, M
Tong, W
Rabbani, F
Donat, SM
Herr, HW
Sogani, P
Depalma, D
Bajorin, D
机构：
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [21] Management of BCG non-responders with fixed dose intravesical gemcitabine in superficial transitional cell carcinoma of urinary bladder
    Mohanty, N. K.
    Nayak, Rajiba L.
    Vasudeva, Pawan
    Arora, R. P.
    [J]. INDIAN JOURNAL OF UROLOGY, 2008, 24 (01) : 44 - 47
  • [22] EFFECTIVENESS OF COMBINATION CISPLATIN-BASED INTRAVESICAL CHEMOTHERAPY FOR BCG-REFRACTORY BLADDER CANCER
    Vila-Reyes, Helena
    Decastro, G. Joel
    Faiena, Izak
    Pak, Jamie S.
    Lee, Kevin
    Li, Gen
    Anderson, Christopher B.
    Abate-Shen, Cory T.
    McKiernan, James M.
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E1124 - E1124
  • [23] Is Intravesical Gene Therapy for Patients with BCG-refractory NMIBC?
    Bohle, A.
    [J]. UROLOGE, 2021, 60 (03): : 372 - 373
  • [24] A phase I study of intravesical suramin for the treatment of superficial transitional cell carcinoma of the bladder
    Uchio, EM
    Linehan, WM
    Figg, WD
    Walther, MM
    [J]. JOURNAL OF UROLOGY, 2003, 169 (01): : 357 - 360
  • [25] Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial
    Perdona, Sisto
    Di Lorenzo, Giuseppe
    Cantiello, Francesco
    Damiano, Rocco
    De Sio, Marco
    Masala, Daniele
    Bruni, Gianni
    Gallo, Luigi
    Federico, Piera
    Quattrone, Carmelo
    Pizzuti, Mariano
    Autorino, Riccardo
    [J]. ANTI-CANCER DRUGS, 2010, 21 (01) : 101 - 106
  • [26] PHASE I/II TRIAL OF INTRAVESICAL NANOPARTICLE ALBUMIN- BOUND PACLITAXEL FOR THE TREATMENT OF BCG REFRACTORY NON-MUSCLE INVASIVE TRANSITIONAL CELL CARCINOMA
    Holder, Dara
    Castaneda, Crystal
    Ahn, Jennifer
    Badalato, Gina
    Barlow, LaMont
    Mann, Mark
    RoyChoudhury, Arindam
    Benson, Mitchell
    Mckiernan, James
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E698 - E698
  • [27] MANAGEMENT OF BCG-REFRACTORY SUPERFICIAL BLADDER CANCER
    Soyupak, Bulent
    [J]. TURKISH JOURNAL OF UROLOGY, 2005, 31 (04): : 465 - 468
  • [28] Phase I Clinical Trial and Pharmacokinetics of Intravesical Mitomycin C in Dogs with Localized Transitional Cell Carcinoma of the Urinary Bladder
    Abbo, A. H.
    Jones, D. R.
    Masters, A. R.
    Stewart, J. C.
    Fourez, L.
    Knapp, D. W.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2010, 24 (05): : 1124 - 1130
  • [29] Nephrotic syndrome as a complication of intravesical BCG treatment of transitional cell carcinoma of urinary bladder
    Singh, N. P.
    Prakash, Anupam
    Kubba, Samir
    Ganguli, Anirban
    Agarwal, S. K.
    Dinda, Amit K.
    Aggarwal, P. N.
    [J]. RENAL FAILURE, 2007, 29 (02) : 227 - 229
  • [30] Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of the bladder
    Campodonico, F
    Maffezzini, M
    [J]. UROLOGY, 2005, 66 (05) : 1141 - 1142
12345